tolbutamide has been researched along with dehydroepiandrosterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Falcone, T; Fantus, IG; Finegood, DT; Morris, D | 1 |
| Giaume, C; Jiménez, C; Medina, JM; Tabernero, A; Velasco, A | 1 |
3 other study(ies) available for tolbutamide and dehydroepiandrosterone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
Topics: Adult; Androgens; Androstenedione; Blood Glucose; Dehydroepiandrosterone; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Obesity; Polycystic Ovary Syndrome; Testosterone; Tolbutamide | 1990 |
The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Arachidonic Acid; Astrocytes; Biological Transport; Cell Communication; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cytarabine; Cytochalasin B; Dehydroepiandrosterone; Endothelin-1; Enzyme Inhibitors; Gap Junctions; Glucose; Glycyrrhetinic Acid; Hypoglycemic Agents; Ouabain; Pentose Phosphate Pathway; Rats; Rats, Wistar; Ribosemonophosphates; Tolbutamide | 2001 |